Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • alittleboy
    Member
    • Apr 2011
    • 60

    #1

    understand the "left" and "right" outputs from NCBI data

    I am trying to understand what do the columns mean for a sequencing dataset that I downloaded from NCBI. The link to the page is http://www.ncbi.nlm.nih.gov/geo/quer...i?acc=GSE49372, and I download the "GSE49372_RAW.tar" file where, after uncompress, we see each sample is summarized in a .txt file. I extract a subset of the first sample as below:

    gene_id bundle_id chr left right FPKM FPKM_conf_lo FPKM_conf_hi status
    YAL069W 12733 I 334 649 0 0 0 OK
    YAL068W-A 12733 I 537 792 0 0 0 OK
    YAL068C 12734 I 1806 2169 2.22061 0 5.20096 OK
    YAL067W-A 12735 I 2479 2707 0 0 0 OK
    YAL067C 12736 I 7234 9016 44.7682 31.3864 58.15 OK
    YAL066W 12737 I 10090 10399 0 0 0 OK

    Here I see the "left" and "right" columns correspond to read counts (is that correct?). Because I want to obtain a read count matrix with rows as genes and columns as samples (as we analyze in edgeR or DESeq), I don't know how can I summarize the "left" and "right" columns for this sample. I appreciate any suggestions
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    I suspect that those are coordinates, which would normally be labeled start/end or something like that. It's likely that you'll have to do that actual counting yourself.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 10:52 AM
    0 responses
    8 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    19 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-13-2026, 09:56 AM
    0 responses
    16 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-09-2026, 11:14 AM
    0 responses
    27 views
    0 reactions
    Last Post SEQadmin2  
    Working...